paclitaxel has been researched along with adriamycinol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosson, EJ; Millward, MJ; Stokes, KH; Webster, LK | 1 |
| Brown, AM; Bryant, J; Dakhil, SR; Davidson, NE; Fehrenbacher, L; Geyer, CE; Ingle, JN; Jenkins, RB; Kaufman, PA; Klein, PM; Kutteh, LA; Lingle, WL; Mamounas, EP; Martino, S; Paik, S; Perez, EA; Pisansky, TM; Romond, EH; Suman, VJ; Swain, SM; Tan-Chiu, E; Visscher, DW; Vogel, VG; Wolmark, N; Yothers, G | 1 |
| Calafiore, AM; Cascegna, S; Gianni, L; Liberi, G; Menna, P; Minotti, G; Salvatorelli, E | 1 |
| Cruz, A; de-Castro-Ríos, A; Lema-Atán, JÁ; Lendoiro, E; López-Rivadulla, M; Paniagua-González, L | 1 |
1 trial(s) available for paclitaxel and adriamycinol
| Article | Year |
|---|---|
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Heart Diseases; Humans; Mastectomy; Middle Aged; Paclitaxel; Proportional Hazards Models; Receptor, ErbB-2; Recurrence; Survival Analysis; Trastuzumab | 2005 |
3 other study(ies) available for paclitaxel and adriamycinol
| Article | Year |
|---|---|
Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Female; Glycerol; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Paclitaxel; Solvents; Time Factors | 1996 |
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapies.
Topics: Aged; Allosteric Regulation; Antineoplastic Agents; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Myocardium; Paclitaxel; Taxoids | 2006 |
LC-MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure.
Topics: Chromatography, Liquid; Cyclophosphamide; Cytostatic Agents; Epirubicin; Etoposide; Gemcitabine; Humans; Irinotecan; Occupational Exposure; Paclitaxel; Tandem Mass Spectrometry; Vinorelbine | 2023 |